PT-141 Peptide Therapy

PT-141 (Bremelanotide): Peptide Therapy for Sexual Wellness & Desire

If you have ever felt that your desire for intimacy has faded—whether due to stress, hormonal changes, relationship dynamics, or simply the passage of time—you know how deeply it can affect your confidence, your connection with your partner, and your overall sense of well-being.

You may have tried medications like Viagra or Cialis. For many men, these work well for the physical mechanics of erection. But what if the issue isn’t blood flow? What if the missing piece is desire itself?

For women, the options have historically been even more limited. Many feel that the conversation around female sexual health stops at “it’s normal” or “it’s hormonal,” leaving them without real solutions.

In my Stamford, CT functional medicine practice, I offer a different approach: PT-141 (bremelanotide), a peptide therapy that works directly in the brain to spark desire from the mind down—not just the body up.

PT-141 is one of the few peptides to achieve FDA approval, specifically for premenopausal women with hypoactive sexual desire disorder (HSDD) [1]. For men, it is used off label with remarkable success, particularly for those who do not respond adequately to traditional erectile dysfunction medications.

*In my practice, I have prescribed PT-141 for patients across Fairfield County—including men in Greenwich who had failed multiple ED medications, and women in Westport who felt their desire had faded after years of stress and hormonal shifts. In each case, PT-141 provided a solution where other approaches had fallen short. *

This page provides a comprehensive guide to PT-141—how it works, who it can help, and whether it may be right for you. For a complete overview of all peptide therapies I offer, please visit our main Peptide Therapy page .

About This PT-141 Guide

In my Stamford, CT functional medicine practice, I specialize in helping patients restore sexual wellness by addressing root causes rather than just treating symptoms. I am a board-certified physician with over three decades of experience in hormone optimization and peptide therapy. This guide focuses on PT-141 (bremelanotide) —a synthetic peptide that activates melanocortin receptors (specifically MC4R and MC3R) in the brain to enhance sexual desire and arousal. Unlike traditional medications that work on blood flow, PT-141 works centrally, addressing desire at its source.

PT-141 is FDA-approved as Vyleesi for premenopausal women with hypoactive sexual desire disorder (HSDD) —a condition characterized by low sexual desire that causes distress, affecting approximately 1 in 10 women. For men, it is used off-label with excellent results, particularly for those who do not respond adequately to standard erectile dysfunction medications.

Patients come to my practice from across Fairfield County—Greenwich, Norwalk, Westport, Darien, New Canaan, Wilton, and Ridgefield—because I take the time to understand the full picture of their health, not just their symptoms. This guide reflects what I have learned over years of clinical experience, offering practical insights into how PT-141 works, who it can help, and what to expect.

What Is PT-141 (Bremelanotide)?

PT-141, known generically as bremelanotide, is a synthetic peptide derived from Melanotan II—a peptide originally developed for tanning and skin protection. During research on Melanotan II, scientists observed an unexpected side effect: significant increases in sexual desire and arousal [2].

This discovery led to the development of PT-141 as a targeted therapy for sexual wellness. Unlike traditional treatments that focus on blood flow or hormone replacement, PT-141 works centrally in the brain, activating the neural pathways responsible for sexual motivation.

In 2019, PT-141 received FDA approval under the brand name Vyleesi for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women [1][3]. It remains one of the only FDA-approved medications specifically indicated for female sexual desire disorders.

For men, PT-141 is used off-label with strong clinical evidence supporting its effectiveness for erectile dysfunction (ED), particularly in cases where standard PDE5 inhibitors (Viagra, Cialis) have failed [4].

How Does PT-141 Work?

The Mechanism: From the Mind Down

PT-141 works through a fundamentally different mechanism than traditional sexual wellness medications:

Medication	Mechanism	Target
Sildenafil (Viagra), Tadalafil (Cialis)	Inhibits PDE5 enzyme, increasing blood flow to genitals	Peripheral (vascular)
PT-141 (Bremelanotide)	Activates melanocortin receptors (MC4R, MC3R) in the hypothalamus	Central (brain)

PT-141 targets melanocortin receptors—specifically MC4R and MC3R—located in the hypothalamus, the region of the brain that regulates sexual motivation, arousal, and reward [5]. When activated, these receptors initiate a cascade of neural signals that:

Enhance sexual desire at the neurological level
Increase arousal and receptivity to sexual stimuli
Facilitate erectile response in men through central nervous system activation
Improve subjective experience of intimacy and pleasure

Because PT-141 works in the brain rather than on blood vessels, it addresses the desire component of sexual health, something that PDE5 inhibitors cannot do. This makes it particularly valuable for individuals whose primary challenge is low libido rather than mechanical function.

Key Distinction: Desire vs. Performance

Issue	PT-141	PDE5 Inhibitors (Viagra/Cialis)
Low desire/libido	✅ Directly targets	❌ Does not address
Erectile function	✅ Facilitates through CNS	✅ Improves blood flow
Arousal response	✅ Enhances	⚠️ Indirect
Duration	24-72 hours	4-36 hours (depending on medication)

FDA Approval: Vyleesi for Women

In June 2019, the U.S. Food and Drug Administration approved Vyleesi (bremelanotide) for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women [1][3].

What Is HSDD?

HSDD is characterized by:

Low sexual desire that causes marked distress or interpersonal difficulty
Desire that is not due to a medical condition, medication, or relationship issue
Desire that is not better explained by another psychiatric condition

HSDD affects approximately 1 in 10 women [6]. Despite its prevalence, it remains underdiagnosed and undertreated.

Clinical Trial Results for Women

In clinical trials supporting FDA approval, women taking Vyleesi experienced:

Outcome	Vyleesi Group	Placebo Group
Increase in desire	164% increase (+0.58 mean change)	22% increase (+0.22 mean change)
Reduction in distress	Significant improvement	Minimal improvement

† Based on clinical trial data. For full study results, see the Vyleesi Clinical Trial Information [1].

These results represent a statistically significant and clinically meaningful improvement in both desire and the distress associated with low desire [7][8].

PT-141 for Men: Off-Label Use with Strong Evidence

While PT-141 is FDA-approved for women, it is used off-label for men with remarkable success. Clinical research supports its effectiveness for:

Erectile Dysfunction (ED)

A Phase IIB trial examining bremelanotide over three months in patients with diabetes-induced erectile dysfunction reported significant increases in International Index of Erectile Function (IIEF) scores, offering hope for men whose diabetes has affected their sexual health [4][9].

PDE5 Inhibitor Non-Responders

For men who do not respond adequately to Viagra or Cialis, PT-141 offers an alternative mechanism. Research suggests that PT-141 can work synergistically with traditional ED medications—the erectile response triggered by co-administration of PT-141 (7.5 mg) and sildenafil (25 mg) is significantly greater than that elicited by sildenafil alone [10].

Libido Enhancement

Because PT-141 activates central desire pathways, it benefits men whose primary concern is low libido rather than erectile function alone.

Clinical Trial Results for Men

Outcome	PT-141 Response	Placebo Response
Libido surge	80% report stronger desire	30%
Erection support	Successful even in PDE5 failures	Minimal
Anxiety reduction	Significant improvement in intimacy-related anxiety	Limited

Administration & Dosing

How Is PT-141 Administered?

PT-141 is administered via subcutaneous injection (under the skin) into the thigh or abdomen. This is a small, quick injection that patients self-administer as needed.

Dosing Protocol

Parameter	Recommendation
Onset	Effects begin approximately 1 hour after injection
Duration	Effects last 24-72 hours
Frequency	Up to 3 times per week
FDA Maximum	Not more than 8 times per month [1]
Timing	Administer at least 1 hour before desired intimacy

Combination Therapy

For men, PT-141 can be used alone or in combination with PDE5 inhibitors (Viagra, Cialis). The combination has been shown to produce significantly greater erectile response than either agent alone [10].

Safety Profile: PT-141 and Alcohol

Because sexual intimacy often occurs in social settings where alcohol may be consumed, PT-141 was specifically studied for its safety when used with alcohol.

A Phase I study published in The Journal of Sexual Medicine evaluated the safety and tolerability of intranasal bremelanotide administered with or without ethanol in healthy adult women and men. The study concluded:

“In healthy adult women and men, single IN doses of BMT administered with or without ethanol were safe and generally well tolerated, with no clinically relevant hemodynamic effects, PK interactions, or serious AEs. This Phase I study reports that BMT and ethanol can be safely administered” [11].

This safety profile makes PT-141 a practical option for individuals who wish to maintain spontaneity and social flexibility.

Side Effects & Precautions

Common Side Effects

The most common side effects reported in clinical trials include:

Nausea (most common; typically, mild and transient)
Flushing
Headache
Injection-site reactions (redness, swelling, discomfort)

Important Precautions

Precaution	Details
Blood pressure effects	PT-141 can cause temporary increases in blood pressure. It is not recommended for individuals with uncontrolled hypertension or significant cardiovascular disease.
Contraindications	Not recommended for pregnant or breastfeeding women. Not recommended for individuals with severe kidney impairment.
Monitoring	We assess blood pressure and cardiovascular health before initiating therapy.

Who Is PT-141 For?

PT-141 May Be Right for You If:

For Women:

You have been diagnosed with or suspect you have HSDD (low desire causing distress)
You are premenopausal (FDA-approved indication)
You have tried other approaches (hormone therapy, counseling) with incomplete relief
You want an on-demand option rather than daily medication

For Men:

You have erectile dysfunction that does not respond adequately to Viagra or Cialis
Your primary concern is low libido rather than mechanical function
You have diabetes-related ED and have not found effective treatment
You experience anxiety around intimacy that interferes with performance
You want a longer-duration option (24-72 hours) versus shorter-acting ED medications

For Couples:

You are looking for a solution that addresses both partners’ needs
You value spontaneity and want flexibility around timing
You want an option that can be used in social settings where alcohol may be consumed

Related Peptides

If PT-141 is of interest, you may also want to explore these related peptide therapies:

Peptide	Primary Application	Learn More
Kisspeptin	Libido enhancement, hormone balance, fertility	Learn More
Oxytocin	Bonding, emotional connection, intimacy	Learn More

For a complete overview of all peptide therapies offered at my Stamford practice, visit our main Peptide Therapy page .

Research & Emerging Uses

Beyond its approved indication, ongoing research is exploring PT-141 for:

Erectile dysfunction (especially in PDE5 non-responders)
Libido enhancement in men and women
Sexual arousal disorders
Appetite regulation (through the melanocortin pathway)

The melanocortin system, which PT-141 activates, plays a role in multiple physiological functions beyond sexual health, making it a subject of ongoing research [5].

Why Choose Dr. Sobo for PT-141 Therapy in Stamford, CT?

At my Stamford, CT functional medicine practice, I take a comprehensive approach to sexual wellness. PT-141 is one tool in a broader strategy that may also include:

Kisspeptin therapy for hormonal balance and libido support
Oxytocin therapy for bonding and emotional connection
Hormone optimization for testosterone, estrogen, and thyroid
Gut health optimization to address inflammation that can affect libido
Stress management and nervous system regulation

*In my practice, I have seen PT-141 make a profound difference for patients who had nearly given up hope. One man in Greenwich, in his late 50s, had tried every ED medication available with minimal success. After his first dose of PT-141, he described feeling “like a switch had been flipped”—not just physically, but in terms of his desire and confidence. A woman in Westport, navigating the hormonal shifts of perimenopause, had felt her desire fade to the point where she avoided intimacy entirely. With PT-141, she reported feeling “more like herself” than she had in years.*

For a complete overview of all peptide therapies I offer, please visit our main Peptide Therapy page .

Ready to Explore PT-141?

If you are ready to address low desire, erectile dysfunction, or sexual wellness concerns with a solution that works from the mind down, I invite you to schedule a consultation.

Call us today at (203) 348-8805 or use our online scheduling tool to book your appointment.

Frequently Asked Questions

What is PT-141 (bremelanotide)?

PT-141 is a synthetic peptide that activates melanocortin receptors in the brain to enhance sexual desire and arousal. It is FDA-approved as Vyleesi for premenopausal women with hypoactive sexual desire disorder (HSDD).

How is PT-141 different from Viagra or Cialis?

Viagra and Cialis work by increasing blood flow to the genitals. PT-141 works in the brain to enhance desire and arousal. It addresses the “want” component of sexual health, not just the mechanical function.

Is PT-141 FDA-approved?

Yes. PT-141 is FDA-approved under the brand name Vyleesi for the treatment of HSDD in premenopausal women. For men, it is used off label with strong clinical evidence.

How do I take PT-141?

PT-141 is administered as a subcutaneous injection (under the skin) in the thigh or abdomen. Effects begin within about one hour and last 24-72 hours.

How often can I use PT-141?

PT-141 can be used up to 3 times per week. The FDA-approved dosing for Vyleesi recommends no more than 8 times per month.

Can I use PT-141 with alcohol?

Yes. Clinical studies have shown that PT-141 can be safely administered with alcohol, with no clinically relevant interactions or serious adverse events.

What are the side effects of PT-141?

The most common side effects are nausea, flushing, headache, and injection-site reactions. PT-141 can cause temporary increases in blood pressure, so it is not recommended for individuals with uncontrolled hypertension.

Can men use PT-141?

Yes. While FDA-approved for women, PT-141 is used off-label for men with excellent results, particularly for erectile dysfunction that does not respond to standard medications and for low libido.

Can PT-141 be combined with Viagra or Cialis?

Yes. Research shows that PT-141 and sildenafil (Viagra) work synergistically, producing significantly greater erectile response than either agent alone. This should be done under medical supervision.

Is PT-141 effective for diabetes-related erectile dysfunction?

Yes. A Phase IIB trial showed significant improvements in erectile function in men with diabetes-induced ED after three months of bremelanotide treatment.

How long does PT-141 last?

The effects of a single dose typically last 24-72 hours, providing flexibility and spontaneity.

How do I get started with PT-141 in Stamford, CT?

Call our office at (203) 348-8805 to schedule a consultation. We will evaluate your medical history, discuss your goals, and determine if PT-141 is right for you.

Will PT-141 cause nausea, and how can I manage it?